Meta description: Integer Holdings Corporation (NYSE: ITGR) shares show modest movement as investors assess its position within the medical device sector.
Company Overview
Integer Holdings Corporation is a US-based medical device outsource manufacturer with operations in the United States, Puerto Rico, Costa Rica, and other international markets. Established in 1970 and headquartered in Plano, Texas, the company is organized into Medical and Non-Medical segments. Its portfolio includes products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, and related medical procedures.
The product lines also extend to cardiac rhythm management devices such as implantable pacemakers and defibrillators, neuromodulation products including spinal cord stimulators, and a variety of surgical tools for orthopedic and general surgeries. Integer serves multinational original equipment manufacturers (OEMs), positioning itself as a critical partner in the healthcare supply chain.
Stock Performance
On the New York Stock Exchange (NYSE), Integer Holdings trades under the ticker ITGR. The latest price reported is USD 105.38, reflecting a slight uptick of 0.34 points or 0.32% from the previous trading session. This places the stock within its 52-week range of USD 99.73 to USD 146.36, showing relative stability around the lower to mid-range levels.
Trading volume stood at 468,454 shares, surpassing the average daily volume of 413,814. Elevated trading activity may indicate increased market interest or short-term positioning by institutional participants. For investors, this data signals moderate volatility but no sharp swings.
Market Position and Sector
Integer operates within the medical devices industry, part of the broader healthcare sector. With a market capitalization of approximately USD 3.69 billion, the company holds a mid-cap designation, which often combines growth potential with established market presence.
The medical device sector is dynamic, driven by innovation, regulatory compliance, and demand from aging populations and rising healthcare investment. Players like Integer are evaluated on their ability to maintain manufacturing quality and deliver complex products at scale.
Governance and Leadership
Integer Holdings is led by CEO Joseph W. Dziedzic, whose leadership is focused on operational efficiency and expanding product offerings. Corporate governance is structured to meet regulatory and stakeholder expectations, with oversight critical in a sector sensitive to compliance standards.
Key Financial Data
Key identifiers for trading and investment include:
- Ticker: ITGR
- ISIN: US45826H1095
- CUSIP: 45826H109
- Exchange: New York Stock Exchange (NYSE)
- Currency: USD
- Market Cap: USD 3,691,969,015
- Last Dividend: 0 (No dividend declared)
- 52-week Range: USD 99.73 – USD 146.36
- Average Volume: 413,814
The absence of dividends indicates Integer reinvests earnings to support growth and operations rather than returning cash to shareholders. This approach is common among companies prioritizing expansion or innovation.
FAQ
- Does Integer Holdings pay dividends? No, the company has a last declared dividend of zero.
- Where is Integer Holdings traded? It is listed on the New York Stock Exchange under the ticker ITGR.
- How many employees does the company have? Integer Holdings employs approximately 11,000 people globally.
- What sector does Integer operate in? The company is in the healthcare sector, specializing in medical devices.
- Who is the current CEO? Joseph W. Dziedzic leads Integer Holdings Corporation.
Conclusion
Integer Holdings Corporation demonstrates stable performance within the medical device industry. The company maintains a solid market capitalization and continues to attract attention through its diverse manufacturing portfolio. Investors may value its mid-cap positioning and industry role, though the lack of dividend may influence income-focused strategies. Ongoing sector trends and leadership direction will shape the company’s future trajectory.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult professional advisors before making investment decisions.
Announcement
For full information about the company, see the link below.